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Abstract
Background: Chinese medicine has been proposed as a novel strategy for the prevention of
metabolic disorders such as obesity. The present study tested 17 Chinese medicinal herbs were
tested for their potential anti-obesity effects.
Methods: The herbs were evaluated in terms of their abilities to stimulate the transcription of
Apolipoprotein A-IV (ApoA-IV) in cultured Caco-2/TC7 enterocytes. The herbs that showed
stimulating effects on ApoA-IV transcription were further evaluated in terms of their abilities to
reduce the formation of triglyceride in differentiated 3T3-L1 adipocytes.
Results: ApoA-IV transcription was stimulated by Rhizoma Alismatis and Radix Angelica Sinensis in a
dose- and time-dependent manner in cultured Caco-2/TC7 cells. Moreover, these two herbs
reduced the amount of triglyceride in differentiated 3T3-L1 adipocytes.
Conclusion: The results suggest that Rhizoma Alistmatis and Radix Angelica Sinensis may have
potential anti-obesity effects as they stimulate ApoA-IV transcription and reduce triglyceride
formation.
Background
Obesity is one of the metabolic disorders attributed to var-
ious factors such as uncontrolled food intake, environ-
ment and lack of exercises. Excessive weight may be a
precursor of serious illnesses including diabetes, heart dis-
ease and cancer [1]. More and more people in China now
live a sedentary lifestyle and consume calorie-rich foods
[2]. Between 1992 and 2002, more than 60 million peo-
ple became obese in China [3] where the prevalence of
obesity is likely to increase [4-6]. By 2020, the obese pop-
ulation in China is expected to surpass that in the United
States [7].
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Chinese Medicine 2009, 4:5 http://www.cmjournal.org/content/4/1/5The current choices for anti-obesity medications are quite
limited and some anti-obesity medicines have serious or
even life-threatening side effects [8]. There is a pressing
need for new and/or alternative treatments against obes-
ity.
Chinese medicine was found useful in preventing and
treating obesity. For example, tea polyphenols, especially
epigallocatechin-3-gallate (EGCG), which increases apop-
tosis in mature adipocyte, was proposed to be a chemo-
preventive agent against obesity [9]. Ginsenoside Rh2
may prevent obesity via the AMPK signaling pathway [10].
Apolipoprotein A-IV (ApoA-IV), a circulating glycoprotein
primarily synthesized in the small intestines during fat
absorption [11], was demonstrated to prevent atheroscle-
rosis by modulating plasma lipoprotein metabolism [12]
and inhibit gastric motility, acid secretion [13-15] and
intestinal motility [16]. More importantly, ApoA-IV may
be involved in the control of food intake [17-19]. Inges-
tion of food containing high lipid content produces chy-
lomicrons, which are absorbed by intestinal cells to trigger
the synthesis and secretion of ApoA-IV into blood [20].
ApoA-IV is also synthesised and regulated in the hypotha-
lamus [21]. Recently, Gotoh et al. suggested that the
action of ApoA-IV took place in our central nervous sys-
tem; high levels of ApoA-IV in blood reduce food intake
by potentiating the anorectic effect of central melanocor-
tin agonists [19]. Hypothalamic melanocortin system is
critical in the regulation of food intake and body weight
[22]. ApoA-IV gene regulation may serve as a negative
feedback circuit to control food intake.
Adipogenesis is another potential target for treating obes-
ity. Several cell types were shown to undergo in vitro lipo-
genic differentiation into adipocytes, including the well
characterized 3T3-L1 pre-adipocytes [23-26]. Induced by a
chemical cocktail, 3T3-L1 cells differentiate to form adi-
pocytes, with the accumulation of triglyceride (TG) as one
of the hallmarks of adipogenesis. The anti-obesity effect
therefore could be represented by the suppression of TG
formation in 3T3-L1 adipocytes.
In the present study, 17 Chinese medicinal herbs were
evaluated for their potential anti-obesity effects in terms
of their abilities to stimulate ApoA-IV expression and TG
formation.
To demonstrate the potential anti-obesity effects of the
Chinese medicinal herbs, we employ an intestinal cell line
Caco-2/TC7 stably transfected by a human ApoA-IV pro-
moter tagged with a firefly luciferase gene [27]. The high
sensitivity in the measurement of luciferase allows us to
evaluate the transcriptional activation or repression of the
ApoA-IV promoter by the herbs. Those herbs with signifi-
cant effects on ApoA-IV transcription were further ana-




The Chinese medicinal herbs in this study were A: Rhizoma
Alismatis (Zexie), B: Fructus Crataegi (Shanzha), C: Semen
Coicis (Yiyiren), D: Rhizoma Atractylodis Macrocephalae
(Baizhu), E:Rhizoma Atractylodis (Cangzhu), F:Sclerotium
Poriae Cocos (Fuling), G: Semen Cassiae (Juemingzi), H:
Folium Sennae (Fanxieye), I: Radix Angelica Sinensis (Dang-
gui), J: Rhizoma Curumae (Ezhu), K: Flos Chrysanthemi
(Juhua), L: Radix Notoginseng (Sanqi), M: Folium Nelum-
binis (Heye), N: Herba Taraxaci (Pugongying), O: Pericar-
pium Citri Reticulatae (Chenpi), P: Fructus Schisandrae
Chinensis (Wuweizi) and Q: Fructus Mori (Sangshen). All
the herbs were purchased from Eu Yan Sang International
Ltd and Tung Fong Hong Medicine Co Ltd in Hong Kong
and were authenticated by organoleptic characteristics
according to the Pharmacopoeia of the People's Republic
of China (2005 edition, volume I). Each experimental
species (300 g) was deposited in the Herbarium of the
Department of Biology, Hong Kong University of Science
and Technology (Additional file 1).
These herbs were divided into two groups. The first group
includes the herbs that treat obesity or obesity-related dis-
eases according to the Pharmacopoeia of the People's
Republic of China and other literature. The second group
includes common dietary herbs not documented to have
functional effects on obesity.
Preparation of herbal extracts
Two methods, namely water and ethanol extractions, were
used to prepare herbal extracts in the present study. In
water extraction, each herb was ground and boiled twice
in eight units of water for one hour. In ethanol extraction,
each grounded herb was immersed in eight units of 95%
ethanol for two hours and reflux for further two hours.
Both water and ethanol extracts were dried into powder
and stored at -80°C.
Cell culture
The stable cell line of Caco-2/TC7 transfected with the
human ApoA-IV promoter was provided by Prof M Lacasa
(Université Pierre et Marie Curie, France). TC7 is the
selected clone from Caco-2 cells [28]. The cells were
grown at 37°C in a water-saturated incubator containing
5% CO2 in Dulbecco's Modified Eagle's Medium (DMEM)
supplemented with 20% heat-inactivated fetal bovine
serum (HI-FBS), 100 U/ml penicillin and 100 g/ml
streptomycin. In all experiments, cells were maintained at
about 90% confluence. The high confluence condition
allowed cell differentiation, which increases the expres-Page 2 of 8
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were seeded on 24-well microtiter plates (40000 cells/
well) for 24 hours. Mouse 3T3-L1 fibroblast cells (ATCC
no.CL-173) were obtained from American Type Culture
Collection (USA) and maintained at 37°C in a water-sat-
urated incubator containing 5% CO2 and in DMEM sup-
plemented with 4.5 g/L glucose, 10% FBS, 100 U/ml
penicillin and 100 g/ml streptomycin. Induction of lipo-
genic differentiation was detailed in a previous study [29].
Briefly, the confluent cultures were treated with a differen-
tiation cocktail containing dexamethasone (1 M, Sigma,
USA), insulin (1.8 M, Sigma, USA) and dibutryl-cAMP
(300 M, Sigma, USA) for 72 hours to induce lipogenesis.
The cultures were set as day 0, and replaced with the cul-
ture medium containing insulin (1.8 M) for every two
days. At day 10, about 80% of cultures were induced to
contain triglyceride (TG). Treatments including serum
starvation (DMEM only), insulin (1.8 M), Radix Angelica
Sinensis and Rhizoma Alistmatis (10, 1 and 0.1 mg/ml
water extracts) were given to differentiated cultures (on
day 10) for 72 hours. Unless described otherwise, all the
culture reagents were purchased from Invitrogen Technol-
ogies (USA).
Preparation of lipid micelles
The lipid micelles was used to mimic the duodenal
micelles resulting from digestion of lipid [30], and pre-
pared according to the method of Carrière et al. [27]. The
stock solution contained 0.6 mM oleic acid, 0.2 mM L--
lysophosphatidylcholine, 0.05 mM cholesterol, 0.2 mM
2-monooleoylglycerol and 2 mM taurocholic acid, and
used in the dilutions from 1:1000 to 1:3000.
Luciferase assay
Luciferase assay was performed with a commercial kit
(Tropix, USA). Briefly, the treated Caco-2/TC7 cells were
collected and re-suspended by 0.2% Triton X-100, 1 mM
dithiothreitol and 100 mM potassium phosphate buffer
(pH7.8). The lysate was subjected to luciferase assay and
protein assay. The luminescent reaction was measured by
Tropix TR717 microplate luminometer, while the protein
concentrations were measured according to the Bradford
method [31] with a protein assay kit (Bio-Rad Laborato-
ries, USA). The luciferase activity reading was normalized
by protein amount in the sample.
Quantitative PCR analysis
Total RNAs, isolated by TRIzol reagent (Invitrogen, USA)
from treated Caco-2/TC7 cultures, were reverse-tran-
scribed to cDNAs by Moloney murine leukemia virus
reverse transcriptase (Invitrogen, USA) according to the
manufacturer's instructions. Quantitative PCR was per-
formed with SYBR Green Master mix and Rox reference
dye according to the manufacturer's instructions (Applied
Biosystems, USA). The primers used for human ApoA-IV
(NM_000482) were 5'-ATG TTC CTG AAG GCC GTG G-3'
and 5'-TGC AGG TCA CCT GCG TAA G-3' (-105 to -334),
and human18S rRNA (NR_003286) 5'-TGT GAT GCC
CTT AGA TGT CC-3' and 5'-GAT AGT CAA GTT CGA CCG
TC-3'(-1494 to -1813). The SYBR green signal was
detected by a quantitative PCR (Mx3000p multiplex,
Stratagene, USA). The relative transcript expression levels
were quantified according to the Ct (cycle threshold)
method [32]. The calculation was done with the Ct value
of 18S rRNA to normalize the Ct value of target gene in
each sample to obtain the Ct value, which was then used
to compare different samples. The PCR products were
analyzed by gel electrophoresis, while the specificity of
amplification was confirmed by melting curve.
Oil red O staining assay
Oil Red O at 0.2% in isopropanol was mixed with water
(3:2, v/v) and filtered. Experimental cultured cells were
washed with PBS, fixed by paraformaldehyde (4% in PBS,
Sigma, USA) for 5 minutes, incubated with filtered Oil
Red O for 30 minutes, and washed twice with PBS. The
stained TG was extracted by isopropanol and its quantity
was measured at 490 nm absorbance [28].
Statistical Analysis
One-way analysis of variance (ANOVA) was carried out
with SPSS software (version 13.0, SPSS, USA). The levels
of statistical significance were P < 0.05 (*), P < 0.01 (**)
and P < 0.001 (***).
Results
Transcriptional activation of ApoA-IV in Caco-2/TC7
ApoA-IV was first chosen for the investigation of anti-
obesity effect due to its potential role in modulating food
intake [17-19]. Accordingly, a promoter-reporter system
containing a human ApoA-IV promoter (about 230 bp)
tagged with a luciferase reporter gene was employed [27].
This reporter construct was stably transfected into cul-
tured Caco-2/TC7 cells for the screening of potential drugs
that regulate the transcriptional activity of ApoA-IV pro-
moter in gut cells. The functionality of this reporter con-
struct was validated by its responsiveness to high
concentration of lipid. Cultured Caco-2/TC7 cells were
treated with lipid micelle (an artificial mixture of lipids
mimicking the duodenal micelles after ingestion) at con-
centrations of 1:1000 and 1:2500. After a 24-hour treat-
ment, total RNAs were extracted to quantify the amount of
ApoA-IV mRNA by a quantitative PCR. Results showed
that the expression of ApoA-IV mRNA was not changed by
the lipid micelle at the concentration of 1:2500, possibly
due to the insufficient amount of lipid micelle to stimu-
late gene transcription (Figure 1A). However, the induc-
tion effect was observed at a higher concentration of
1:1000; the ApoA-IV mRNA was up-regulated to nearly 6
folds compared with the buffer-treated control (FigurePage 3 of 8
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high-fat diet increases the ApoA-IV expression in gut cells
[30].
To assess the transcriptional activity of the ApoA-IV pro-
moter, we treated Caco-2/TC7 cells with various concen-
trations of lipid micelles (1:1000 to 1:3000) for 48 hours
and then collected them for luciferase activity. The addi-
tion of lipid micelles increased the promoter's activity in
a dose-dependent manner. Induction of over six folds was
observed in the Caco-2/TC7 cells treated with 1:1000 lipid
micelles (Figure 1B). The concentrations of lipid micelles
from 1:2000 to 1:1000 were effective in activating the pro-
moter, which was consistent with the findings that ApoA-
IV mRNA expression with a concentration at 1:2500 did
not produce any response (Figure 1A and Figure 1B).
Finally, the optimal treatment time was determined for
inducing ApoA-IV promoter activity by lipid micelles.
Cultures were treated with two concentrations of lipid
micelles (1:2500 and 1:2000) at various time points (i.e.
24, 48 and 72 hours). The promoter activity induced by
lipid micelles at 48 hours was similar to that at 72 hours,
suggesting that treatment time of 48 hours was sufficient
for activation (Figure 1C). Activation was not observed at
1:2500. Therefore, the ApoA-IV promoter is a suitable
screening tool in Caco-2/TC7 enterocytes.
Effects of Chinese medicinal herbs on ApoA-IV 
transcription
Water and ethanol extracts of 17 Chinese medicinal herbs
in water and ethanol extractions were screened for their
effect in regulating ApoA-IV promoter activity in cultured
Caco-2/TC7. The herbs were divided into two groups,
namely those that are used to treat obesity (A-H) and
those that are not used to treat obesity (I-Q). The powders
of water and ethanol extracts of these herbs were dissolved
in water and DMSO respectively. The pH value of each
solution in the medium was measured to ensure that the
cell culture condition was not affected by the addition of
the herb itself. The results showed that more than half of
the herbs in both groups induced the ApoA-IV promoter
activity (Figure 2). In the anti-obesity herb group, Rhizoma
Alismatis (A), Fructus Crataegi (B), Semen Coicis (C), Rhi-
zoma Atractylodis Macrocephalae (D) and Rhizoma Atractylo-
dis (E) increased the ApoA-IV promoter activity by more
than two folds (Figure 2). Moreover, both water and eth-
anol extracts of the herbs demonstrated similar effects,
suggesting high availability of active ingredients in the
herbs. In the group of herbs not documented for anti-
obesity treatment, Radix Angelica Sinensis (I), Rhizoma Cur-
cumae (J), Flos Chrysanthemi (K), Radix Notoginseng (L),
Folium Nelumbinis (M) and Herba Taraxaci (N) signifi-
cantly up-regulated the transcriptional activity of ApoA-IV
promoter after 48 hours of treatment (Figure 2).
Transcriptional activation of ApoA-IV mRNA by lipid micellesFigur  1
Transcriptional activation of ApoA-IV mRNA by lipid 
micelles. A: Caco-2/TC7 cells were treated with lipid 
micelles (1:1000 and 1:2500) for 24 hours. Total RNAs were 
extracted and reverse transcribed to cDNA for real-time 
PCR analysis. The mRNA levels of ApoA-IV were deter-
mined by the Ct-value method and normalized by mRNA 
level of a house keeping gene 18S rRNA. B: Caco-2/TC7 
cells were treated with various concentrations of lipid 
micelles for 48 hours. Cultures were collected for luciferase 
assay to determine ApoA-IV transcription. C: Caco-2/TC7 
cells were treated with lipid micelles (1:2500 and 1:2000) for 
24, 48 and 72 hours to measure the time-dependent regula-
tion of ApoA-IV. Data are expressed as mean ± SD of the 
multiple of Basal (i.e. buffer-treated control set as one) and 
number of independent experiments (n) = 5.Page 4 of 8
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Sinensis (I) were further examined for their dose-depend-
ent effect in Caco-2/TC7. After 48 hours of treatment at
various concentrations (0 to 10 mg/ml), the luciferase
activity was stimulated gradually in response to the
increase concentrations of extracts (Figure 3A). Lastly, the
same activation effect of Rhizoma Alismatis and Radix
Angelica Sinensis in up-regulating the ApoA-IV mRNA
expression was revealed in treated Caco-2/TC7 cells (Fig-
ure 3B). Lipid micelles served as the positive control for
mRNA analysis. These results showed that Rhizoma Alis-
matis and Radix Angelica Sinensis stimulated the ApoA-IV
promoter activity.
Inhibition of lipogenesis in differentiated 3T3-L1 
adipocytes
The 3T3-L1 pre-adipocyte model for adipogenesis studies
[28,33,34] was employed to further determine the anti-
obesity activity of Rhizoma Alismatis and Radix Angelica
Sinensis. Induced by a chemical cocktail, the pre-adi-
pocytes were differentiated, indicated by morphological
changes and accumulation of triglyceride (TG). The TG
vesicles inside the cells were stained by Oil Red O dye for
visualization and quantification. The differentiated 3T3-
L1 cells were serum-starved or treated with insulin for
three days to confirm that TG formation did respond to
changes. The TG content decreased about 50% in the
serum starvation group, and increased to 160% in the
insulin group (Figure 4A). The differentiated 3T3-L1 cells
were treated with various concentrations of Rhizoma Alis-
matis and Radix Angelica Sinensis for three days. With the
addition of 10 mg/ml and 1 mg/ml water-extracts, both
Rhizoma Alismatis and Radix Angelica Sinensis reduced the
TG levels to varying extents (Figure 4B); the most signifi-
cant effect (over 30% TG reduction) was observed in Radix
Angelica Sinensis treatment at 10 mg/ml. These results
showed that both Rhizoma Alismatis and Radix Angelica
Sinensis inhibited the formation of TG.
Discussion
The potential of some Chinese medicinal herbs against
obesity in terms of stimulating ApoA-IV promoter activity
in gut cells and reducing TG content in adipocytes was
tested in the present study. Rhizoma Alismatis (A), Fructus
Crataegi (B), Semen Coicis (C), Rhizoma Atractylodis Macroc-
zphalae (D), Rhizoma Atractylodis (E) and Sclerotium Poriae
Cocos (F), the herbs tradtionally used to treat obesity, were
shown to activate ApoA-IV promoter activity in Caco-2/
TC7 cells. In addition, the extract of Fructus Crataegi (B) in
hyperlipidemia mice displayed the lipid regulating func-
tion [35]. The dehydrotrametenolic acid isolated from
Sclerotium Poriae Cocos (F) promotes the differentiation of
adipocyte in vitro and acts as an insulin sensitizer in vivo
[36]. Rhizoma Alismatis (A) was shown to have in vitro anti-
diabetic effect [37] and it is involved in an herbal formu-
lation for lowering plasma glucose [38]. These findings,
together with our data in stimulating ApoA-IV promoter,
were in agreement with the traditional prescription of
those TCMs for anti-obesity activity. In contrast, Semen
Cassiae (F) and Folium Sennae (H) did not exert any stim-
ulatory effect on promoter activity here. A possible expla-
nation would be that single herb might not be effective in
targeting obesity. The promising biological effect would
be obtainable only in the presence of other appropriate
Transcriptional activation of ApoA-IV by Chinese medicinal herbsFigure 2
Transcriptional activation of ApoA-IV by Chinese medicinal herbs. Caco-2/TC7 cells were treated in various groups 
with water (1 mg/ml) or ethanol (0.1 mg/ml) extracts of the Chinese medicinal herbs for 48 hours. Luciferase activity was 
measured. Left: A: Rhizoma Alismatis; B: Fructus Crataegi; C: Semen Coicis;D: Rhizoma Atractylodis Macroczphalae; E: Rhizoma 
Atractylodis; F: Sclerotium Poriae Cocos; G: Semen Cassiae; H: Folium Sennae); Right: I: Radix Angelica Sinensis; J: Rhizoma Curcumae; 
K: Flos Chrysanthemi; L: Radix et Rhizoma Notoginseng; M: Folium Nelumbinis; N: Herba Taraxaci; O: Pericarpium Citri Retiiculatae; 
P: Fructus Schisandrae; Q: Frutus Mori. Data are expressed as mean ± SD of the multiple fold of control (i.e. buffer-treated con-
trol set as one) and number of independent experiments (n) = 5; P < 0.05 (*); P < 0.01 (**).Page 5 of 8
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Chinese Medicine 2009, 4:5 http://www.cmjournal.org/content/4/1/5Reduction of TG content by Radix Angelica Sinensis and Rhi-zoma Alismatis in differ tiated 3T3-L1 adipocytesFig re 4
Reduction of TG content by Radix Angelica Sinensis 
and Rhizoma Alismatis in differentiated 3T3-L1 adi-
pocytes. A: Lipogenic differentiated 3T3-L1 cells were 
either serum-starved or treated with insulin (10 g/ml) for 
three days, and then stained by Oil red O dye. The amount 
of stained TG (red color) was quantified at 490 nm absorb-
ance. B: Lipogenic differentiated 3T3-L1 cells were treated 
with Rhizoma Alismatis and Radix Angelica Sinensis (0.1, 1 and 
10 mg/ml) for 72 hours. The reduction of TG content was 
measured. Data are expressed as mean ± SD of the percent-
age of control (i.e. water-treated control set as 100) and 
number of independent experiments (n) = 5; P < 0.01 (**); P 
< 0.001 (***).
Stimulation of ApoA-IV mRNA by Rhizoma Alismatis and Radix Angelica SinensisFigure 3
Stimulation of ApoA-IV mRNA by Rhizoma Alismatis 
and Radix Angelica Sinensis. A: Caco-2/TC7 cells were 
treated with water extracts (0–10 mg/ml) of Rhizoma Alisma-
tis and Radix Angelica Sinensis for 48 hours. Luciferase activity 
was measured. B: Caco-2/TC7 cells were treated with Rhi-
zoma Alismatis and Radix Angelica Sinensis (1 mg/ml) for 24 
hours. The change of ApoA-IV mRNA was determined by 
RT-PCR analysis. Data are expressed as mean ± SD of the 
multiple of Basal (i.e. water-treated control set as one) and 
number of independent experiments (n) = 5.
herbs in a decoction mixture. The uniqueness of a precise
combination of different herbs is demonstrated in a tradi-
tional decoction Danggui Buxue Tang; the chemical com-
positions and biological efficacies significantly controlled
by Radix Astragali and Radix Angelica Sinensis at a 5:1 ratio
[39-42].
It is worth noting that some herbs from the Chinese
medicinal herbs not traditionally used to treat obesity (I-
Q), such as Radix Angelica Sinensis (I) and Radix Notogin-
seng (L) induced ApoA-IV transcription. Radix Angelica
Sinensis is traditionally used to treat menstrual disorders
[43,44] and modulate the immune system [45]. Radix
Notoginseng is used to promote blood circulation, remove
blood stasis, induce blood clotting, relieve swelling and
alleviate pain [46-48]. The present study shows that Radix
Angelica Sinensis (I), Rhizoma Curcumae (J), Flos Chrysan-
themi (K), Radix Notoginseng (L), Folium Nelumbinis (M)Page 6 of 8
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and may also be used to treat obesity.
Adipocytes are in the adipose tissue where triacylglycerol
is stored as a fuel for the body. Excess adipose tissue can
lead to insulin resistance, thereby increasing the risk of
type II diabetes and cardiovascular diseases [49]. Adipo-
genesis of 3T3-L1 pre-adipocyte cells is often used in anti-
obesity studies. The mature adipocytes have cytoplasmic
lipid vesicles containing newly synthesized TG [49]. In the
present study, we found that both Rhizoma Alistmatis (A)
and Radix Angelica Sinensis (I) effectively decreased fat
accumulation in 3T3-L1 adipocytes in a dose-dependent
manner; Radix Angelica Sinensis treatment reduced TG
content up to 40% at a dose of 10 mg/ml. These findings
suggest that Rhizoma Alismatis and Radix Angelica Sinensis
may possess multi-functional activities against obesity.
Conclusion
The present study suggests that Rhizoma Alistmatis and
Radix Angelica Sinensis may be potentially useful in treat-
ing obesity as they stimulate ApoA-IV transcription and
reduce TG formation.
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